48 results
8-K
EX-10.1
VBIV
VBI Vaccines Inc.
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
-party in any “derivative” transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities … of the Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing
424B5
VBIV
VBI Vaccines Inc.
11 Apr 24
Prospectus supplement for primary offering
9:06am
, individual plans, individual retirement accounts, and tax-deferred accounts;
S-17
persons holding our common shares or Warrants as part of a hedging … or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition
424B5
VBIV
VBI Vaccines Inc.
7 Jul 23
Prospectus supplement for primary offering
5:25pm
warrants as part of a hedging or conversion transaction straddle or other integrated or risk reduction transaction;
persons who or that are, or may … and trading, commercial and investment banking, advisory, investment management, investment research, principal investment, hedging, market making
424B5
ymdtf2g1eaaa
7 Jul 23
Prospectus supplement for primary offering
5:20pm
424B5
qodk oso7
5 Jul 23
Prospectus supplement for primary offering
4:31pm
8-K
EX-10.1
nga1qn9cnhllbt7 zkn0
15 Sep 22
VBI Vaccines Secures $100 Million Debt Facility From K2 HealthVentures
5:01pm
424B5
pns dr97k5k9e3z
3 Sep 21
Prospectus supplement for primary offering
8:01am